olivlawolivlaw

olivLaw · US equity research

CareTrust REIT, Inc. CTRE

Real Estate Investment Trusts · SIC 6798 · Vertical: Real Estate Investment Trusts (SIC 6798)

37.95USD+3.38% · 1 dayClose 04 Nov 2026

CareTrust REIT (CTRE) is a self-administered REIT that owns, finances and leases healthcare properties, mainly skilled nursing facilities and senior housing, almost entirely under triple-net leases. As of June 30, 2026 its portfolio included 426 properties, and investment activity closed in the second quarter of 2026 totaled 899.6 million USD at a blended stabilized yield of 8.9%.

At the close of 04 Nov 2026, CareTrust REIT, Inc. (CTRE) stock was 37.95 USD (+3.38% on the day), with market capitalisation 9.0 bn USD, P/E 23.9 on diluted EPS of 1.59 USD over the last 12 months, dividend yield 3.82%, beta 0.15, 52-week range 35.45–43.40 USD. Latest reported quarter (Q2 2026): revenue of 161.3 m USD (+43.5% YoY), net income of 89.0 m USD (+29.8% YoY), diluted EPS 0.38 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
9.0 bn USD
shares as of 05 Aug 2026
P/E (TTM)
23.9
Diluted EPS TTM 1.59 · TTM to 30 Jun 2026
E/P (TTM)
4.19%
TTM to 30 Jun 2026
Dividend yield
3.82%
DPS 12m 1.45
Beta (2y)
0.15
Volatility (1y) 25%
52-week range
35.4543.40

Price history

Loading chart…

Technical reading

RSI (14)
59.5
strong (55–70)
Bollinger (20, 2)
35.33 – 37.43
above the upper band · %B 1.25 · band width 5.8%
SMA 50 / 200
37.36 / 39.00
mixed trend
MACD (12, 26, 9)
-0.12 / -0.32
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month+4.8%−1.1%+5.9 pp—
3 months−7.8%−0.5%−7.3 pp—
6 months−3.9%+4.4%−8.3 pp—
Year to date+5.0%+12.3%−7.4 pp—
1 year+7.2%+13.5%−6.3 pp+3.0%
3 years+75.0%+76.4%−1.4 pp+12.5%
5 years+79.9%+63.7%+16.2 pp—
Max drawdown (1y)
−18.3%
21 Jul 2026 → 28 Oct 2026
Max drawdown (5y)
−30.1%
11 Jan 2022 → 29 Apr 2022
Compound annual growth (5y)
+12.5%
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q2 2026 · 30 Jun 2026

Revenue
161.3 m USD
+43.5% YoY
Net income
89.0 m USD
+29.8% YoY
Diluted EPS
0.38
+8.6% YoY
net / operating
55.2% / unavailable

Quarterly margins

Quarterly statements · USD

Fiscal yearQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue77.4 m86.9 m96.6 m112.5 m132.4 m134.9 m142.8 m161.3 m
Depreciation & amortisation14.0 m15.5 m17.8 m21.2 m26.7 m27.1 m29.4 m30.4 m
Interest expense8.3 m5.1 m6.7 m13.0 m12.6 m11.4 m11.2 m15.3 m
Pre-tax income33.3 m52.0 m65.2 m68.9 m77.0 m114.2 m81.8 m90.8 m
Income tax0001.0 m2.1 m1.9 m2.3 m2.5 m
Net income33.4 m52.1 m65.8 m68.5 m74.9 m111.3 m80.2 m89.0 m
Diluted EPS0.210.29 ≈0.350.350.350.50 ≈0.360.38
Operating cash flow67.2 m ≈75.2 m71.4 m100.8 m ≈100.9 m ≈121.0 m90.4 m134.7 m ≈
Dividends paid44.7 m ≈49.7 m54.4 m63.1 m ≈67.1 m ≈74.8 m74.8 m88.5 m ≈

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 8 percentile of its own 37-quarter history (min 20.9, median 31.7, max 266.7; quarters with earnings only).

Fiscal years

Fiscal year20182019202020212022202320242025
Revenue156.9 m163.4 m178.3 m192.4 m196.1 m217.8 m296.3 m476.4 m
Revenue YoY+18.0%+4.1%+9.1%+7.9%+2.0%+11.0%+36.1%+60.8%
Net income57.9 m46.4 m80.9 m72.0 m-7.5 m53.7 m125.1 m320.5 m
Net income YoY+123.9%−20.0%+74.4%−11.0%−110.4%unavailable+132.8%+156.3%
Diluted EPS0.720.490.850.74-0.080.500.801.57
Diluted EPS YoY+105.7%−31.9%+73.5%−12.9%−110.8%unavailable+60.0%+96.2%
net %36.9%28.4%45.3%37.4%-3.8%24.7%42.2%67.3%
Free cash flow97.6 m123.4 munavailableunavailableunavailableunavailableunavailableunavailable

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
198.0 m USD
Financial debt
894.2 m USD
Net debt
696.2 m USD
Equity
4.0 bn USD
Total assets
5.1 bn USD
Debt / equity
0.22x
Current ratio
unavailable
ROE
9.2%
ROA
7.5%
FCF margin
unavailable

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2023
217.8 m
2024
296.3 m
2025
476.4 m

SEC (XBRL)· 12 Feb 2026verified

Cost of revenue
2023
—
2024
—
2025
—

SEC (XBRL)· 16 Feb 2022verified

Gross profit
2023
—
2024
—
2025
—

SEC (XBRL)· 16 Feb 2022derived

Depreciation & amortisation
2023
51.2 m
2024
56.8 m
2025
92.9 m

SEC (XBRL)· 12 Feb 2026verified

Interest expense
2023
40.9 m
2024
30.3 m
2025
43.7 m

SEC (XBRL)· 12 Feb 2026verified

Pre-tax income
2023
53.7 m
2024
124.4 m
2025
325.3 m

SEC (XBRL)· 12 Feb 2026verified

Income tax
2023
0
2024
0
2025
5.0 m

SEC (XBRL)· 12 Feb 2026verified

Net income
2023
53.7 m
2024
125.1 m
2025
320.5 m

SEC (XBRL)· 12 Feb 2026verified

Diluted EPS
2023
0.50
2024
0.80
2025
1.57

SEC (XBRL)· 12 Feb 2026verified

Weighted average diluted shares
2023
106.2 m
2024
155.2 m
2025
204.1 m

SEC (XBRL)· 12 Feb 2026verified

Dividend per share
2023
1.12
2024
1.16
2025
1.34

SEC (XBRL)· 12 Feb 2026verified

Balance sheet · USD

Cash
2023
294.4 m
2024
213.8 m
2025
198.0 m

SEC (XBRL)· 12 Feb 2026verified

Intangibles (excl. goodwill)
2023
—
2024
3.5 m
2025
48.8 m

SEC (XBRL)· 12 Feb 2026verified

Total assets
2023
2.1 bn
2024
3.4 bn
2025
5.1 bn

SEC (XBRL)· 12 Feb 2026verified

Long-term debt
2023
595.6 m
2024
396.9 m
2025
894.2 m

SEC (XBRL)· 12 Feb 2026verified

Total liabilities
2023
666.1 m
2024
507.6 m
2025
1.1 bn

SEC (XBRL)· 12 Feb 2026verified

Equity
2023
1.4 bn
2024
2.9 bn
2025
4.0 bn

SEC (XBRL)· 12 Feb 2026verified

Cash flow · USD

Operating cash flow
2023
154.8 m
2024
244.3 m
2025
394.0 m

SEC (XBRL)· 12 Feb 2026verified

Investing cash flow
2023
-267.8 m
2024
-1.5 bn
2025
-1.5 bn

SEC (XBRL)· 12 Feb 2026verified

Financing cash flow
2023
394.3 m
2024
1.2 bn
2025
1.1 bn

SEC (XBRL)· 12 Feb 2026verified

Dividends paid
2023
115.5 m
2024
172.2 m
2025
259.3 m

SEC (XBRL)· 12 Feb 2026verified

Computed indicators

Growth

Revenue growth (YoY)
60.8%
computed by olivLawFY 2025
Revenue CAGR 3Y
34.4%
computed by olivLawFY 2022 → FY 2025
Revenue CAGR 5Y
21.7%
computed by olivLawFY 2020 → FY 2025
EBIT growth (YoY)
unavailable
input data missing
Net income growth (YoY)
156.3%
computed by olivLawFY 2025
Net income CAGR 3Y
unavailable
the base of the ratio is not positive
Net income CAGR 5Y
31.7%
computed by olivLawFY 2020 → FY 2025
EPS growth (YoY)
96.3%
computed by olivLawFY 2025
EPS CAGR 3Y
unavailable
the base of the ratio is not positive
EPS CAGR 5Y
13.1%
computed by olivLawFY 2020 → FY 2025
FCF growth (YoY)
unavailable
input data missing

Profitability

Gross margin
unavailable
input data missing
EBITDA margin
unavailable
input data missing
EBIT margin
unavailable
input data missing
Net margin
62.2%
computed by olivLawTTM to 30 Jun 2026
FCF margin
unavailable
input data missing

Returns

ROE
9.1%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROA
6.7%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROIC
unavailable
input data missing
ROCE
unavailable
input data missing
Payout ratio (EPS)
91.3%
computed by olivLawTTM to 30 Jun 2026
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
1.2 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
Net debt / EBITDA
unavailable
input data missing
Debt / equity
0.3x
computed by olivLawbalance sheet at 30 Jun 2026
Interest coverage
unavailable
input data missing

Liquidity

Current ratio
unavailable
input data missing
Cash ratio
unavailable
input data missing

Cash

Operating cash flow
447.0 m USD
computed by olivLawTTM to 30 Jun 2026
Capital expenditure
unavailable
input data missing
Free cash flow
unavailable
input data missing
Cash conversion
unavailable
input data missing

Market and valuation

Market capitalisation
9.0 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
Enterprise value
10.1 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
Market cap / net income TTM
25.2x
computed by olivLawTTM to 30 Jun 2026
P/E (TTM)
23.9x
computed by olivLawTTM to 30 Jun 2026
Earnings yield
4.2%
computed by olivLawTTM to 30 Jun 2026
P/B
2.0x
computed by olivLawbalance sheet at 30 Jun 2026
P/S
15.7x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
17.7x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Dividend yield
3.8%
computed by olivLawTTM to 30 Jun 2026
Shareholder yield (distributions)
3.4%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026

9 indicators that do not apply to the sector.

Valuation

olivLaw classification

Unattractive profile

Score: 56 / 100

A scoring methodology on indicators and valuation, not investment advice.

(margin_of_safety <= -0.25 & agreement in ['high', 'medium'])

Closing price

37.95 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 9.0 bn USD

Key indicators

Market capitalisation
9.0 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
P/E (TTM)
23.9x
computed by olivLawTTM to 30 Jun 2026
P/B
2.0x
computed by olivLawbalance sheet at 30 Jun 2026
EV/EBITDA
unavailable
input data missing
ROE
9.1%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Net margin
62.2%
computed by olivLawTTM to 30 Jun 2026
Revenue growth (YoY)
60.8%
computed by olivLawFY 2025
Dividend yield
3.8%
computed by olivLawTTM to 30 Jun 2026

Coverage and freshness

21/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Jun 2026
Latest balance sheet date: 30 Jun 2026
Share count (cover of the latest filing), as of: 05 Aug 2026
Source: SEC (XBRL)published 06 Aug 2026
verified 1404derived 96

Score by group

  • Growth100
  • Valuation50
  • Quality74
  • Returns39

Estimated value range

Low
18.32
USD per share
Mid
25.36
USD per share
High
38.31
USD per share
Price: 37.95 USD
The price is within the range
Potential to the central value: -33.2% (value / price − 1)
Margin of safety: -49.6% (1 − price / value)
Agreement between methods: high · 2 methods used · 2 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 17.61 – 52.94 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • Net asset value (NAV)unavailable · input data missing
  • Dividend discount (DDM)17.61 – 23.68 (Mid 20.20)
  • Peers: P/B19.03 – 52.94 (Mid 30.52)
    32 companies used · median multiple 1.6x · quartiles 1.0x – 2.8x
    ABR, ACRE, ADC, APLE, ARI, ARR, BRX, CDP, CMCT, CUBE, DLR, EPR, EPRT, ESS, EXR, FCPT, FSP, HST, IHT, ILPT, KIM, LINE, O, OLP, PINE, PLD, PSA, RYN, VICI, VMRK, VTR, WELL
Multiple comparisons use the SIC vertical: Real Estate Investment Trusts (SIC 6798)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Unattractive profile · Score 56/100

FactorValueScoreWeight used
ROE · Quality9.1%74 (vs peers)10%
EBITDA margin · Qualityunavailableunavailable—
Revenue CAGR 3Y · Growth34.4%100 (on a fixed band)14%
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheetunavailableunavailable—
P/B · Valuation2.0x44 (vs peers)31%
P/E (TTM) · Valuation23.9x63 (vs peers)14%
Dividend yield · Returns3.8%38 (vs peers)24%
Payout ratio (EPS) · Returns91.3%41 (on a fixed band)7%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet· partialunavailable · 0/2 factors with a value
  • Growth100/100 · 1/1 factors with a value
  • Quality· partial74/100 · 1/2 factors with a value
  • Returns39/100 · 2/2 factors with a value
  • Valuation50/100 · 2/2 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

CareTrust REIT, Inc. (CTRE). Latest full fiscal year: 2025; data up to 2026-06-30.

Figures computed from the financial statements: revenue 476.4 m USD in 2025; YoY growth 60.8%; net margin 62.2%; ROE 9.1%.

The estimated value range is 18.32–38.31 USD per share (median of 2 methods, agreement: high); assumptions are illustrative. Against the central value of 25.36 USD, the price of 37.95 USD leaves a potential of -33.2% (value / price − 1) and a margin of safety of -49.6% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 56/100, methodological classification: unattractive profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: balance, quality. Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • ROE: 9.1%
  • Revenue CAGR 3Y: 34.4%

What contradicts it

No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.

Not assessed (insufficient data or a ratio without meaning): EBITDA margin, Net debt / EBITDA, Interest coverage.

Versus the vertical median

Real Estate Investment Trusts (SIC 6798) · same industry (4-digit SIC) · compared with 39 companies

Multiples and returns vs the median

P/E
23.9x
vertical median 30.5x
below median (−21.6%)
EV/EBITDA
—
vertical median 16.5x
P/S
15.7x
vertical median 7.2x
above median (+117.2%)
P/B
2.0x
vertical median 1.7x
above median (+20.7%)
ROE
9.1%
vertical median 6.3%
above median (+45.7%)
Net margin
62.2%
vertical median 22.4%
above median (+177.4%)
EBIT margin
—
vertical median 32.5%
Revenue YoY
60.8%
vertical median 5.1%
above median (+1,101.6%)
Net debt/EBITDA
—
vertical median 5.2x
Dividend yield
3.8%
vertical median 4.4%
below median (−12.7%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
WELLWelltower Inc.181.9 bn106.24.0%12.7%+35.6%+19% / +178%
PLDPrologis, Inc.122.5 bn33.17.1%42.5%+7.2%+2% / +14%
EQIXEquinix Inc104.3 bn63.311.5%16.4%+5.4%+40% / +29%
AMTAmerican Tower Corporation90.4 bn27.390.6%30.7%+5.1%+7% / −7%
DLRDigital Realty Trust, Inc.65.0 bn48.36.2%21.7%+10.0%+15% / +33%
PSAPublic Storage64.0 bn34.916.0%37.8%+2.7%+25% / +32%
ORealty Income Corporation56.3 bn40.83.6%22.9%+9.1%+3% / +10%
VTRVentas, Inc.47.2 bn167.81.9%4.0%+18.5%+11% / +95%
CCICrown Castle Inc.39.2 bn48.6—20.1%−4.4%+1% / −21%
IRMIron Mountain Inc35.3 bn84.0—5.7%+12.2%+37% / +85%
EXRExtra Space Storage Inc.33.6 bn32.77.9%29.9%+3.7%+21% / +24%
VICIVICI Properties Inc.27.8 bn11.68.3%56.5%+4.1%−12% / −16%
VMRKVivmark Residential23.9 bn27.98.1%—+4.8%+3% / +12%
SBACSba Communications Corporation20.7 bn21.1—34.5%+5.1%+1% / −21%
HSTHost Hotels & Resorts, Inc.17.9 bn17.515.8%16.5%+7.6%+48% / +49%
ESSEssex Property Trust, Inc.17.5 bn41.78.0%22.7%+6.4%+3% / +27%
KIMKimco Realty Corporation17.4 bn28.65.8%27.8%+5.1%+25% / +34%
CUBECubesmart10.4 bn32.311.8%28.7%+5.3%+23% / +15%
BRXBrixmor Property Group Inc.9.3 bn22.014.2%30.0%+6.7%+16% / +40%
ADCAgree Realty Corporation9.1 bn35.83.8%29.8%+16.4%−7% / +18%
CTRECareTrust REIT, Inc.9.0 bn23.99.1%62.2%+60.8%+7% / +75%
LINELineage, Inc.8.8 bn—-2.0%-3.1%+0.3%+8% / unavailable
EPRTEssential Properties Realty Trust, Inc.6.2 bn22.96.3%41.0%+24.8%−11% / +18%
RYNRayonier Inc.6.1 bn6.712.8%68.6%−51.0%−9% / −34%
EPREpr Properties4.7 bn16.812.7%38.8%+2.9%+16% / +36%

1- and 3-year price returns: for CTRE from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
23.48
Total return -35% · Per year -35%
41.33
Total return 13% · Per year 13%
61.99
Total return 68% · Per year 68%
3 years
27.86
Total return -16% · Per year -6%
54.66
Total return 58% · Per year 17%
89.27
Total return 153% · Per year 36%
5 years
33.04
Total return 6% · Per year 1%
72.28
Total return 119% · Per year 17%
128.55
Total return 276% · Per year 30%
What moves the 3-year price the most
  • Exit P/E± 13.66
  • Net margin± 9.56
  • Annual revenue growth± 7.13
  • Annual dilution± 0.80

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

CareTrust REIT (CTRE) is a self-administered REIT that owns, finances and leases healthcare properties, mainly skilled nursing facilities and senior housing, almost entirely under triple-net leases. As of June 30, 2026 its portfolio included 426 properties, and investment activity closed in the second quarter of 2026 totaled 899.6 million USD at a blended stabilized yield of 8.9% 123.

SWOT

Strengths

  • The company has moderate leverage and access to several funding sources, including unsecured credit lines and equity programs 3.
  • Rent collection has remained nearly complete, which points to good quality among current tenants 23.
  • The portfolio is geographically diverse, with properties across several U.S. states and in the United Kingdom 1.

Weaknesses

  • Reliance on a few large tenants, especially one operator, makes revenue sensitive to that partner's financial problems 1.
  • The SHOP platform brings operating costs and risks that the company does not control directly 1.
  • Exposure to the United Kingdom brings currency risk and the integration challenges of complex acquisitions 12.

Opportunities

  • A steady investment pipeline and high stabilized yields could support growth in the coming years 3.
  • A fragmented sector offers opportunities to acquire and consolidate smaller operators 1.
  • Expanding the SHOP platform could diversify revenue beyond fixed rents 13.

Threats

  • Medicaid rate cuts or regulatory changes could weaken tenants' ability to pay 12.
  • High interest rates could raise the cost of capital and reduce the appeal of new acquisitions 2.
  • Bankruptcy or financial distress of a major tenant could lead to income losses and recovery costs 1.

Risks

  • Dependence on Ensignhigh

    A significant share of rent comes from Ensign, and problems at that operator could directly affect the company's revenue 1.

  • Tenant insolvencyhigh

    Tenants could fall behind on payments or enter bankruptcy, which could lead to lease termination and lost revenue 1.

  • Reimbursement regulationmedium

    Changes to Medicare and Medicaid rates could reduce tenant revenue, especially in states under budget pressure 12.

  • Cost of financingmedium

    Rising interest rates and market volatility could weigh on acquisitions and debt refinancing 2.

  • Currency and international risklow

    Activity in the United Kingdom exposes the company to GBP/USD exchange moves and foreign regulatory change 13.

Investment thesis

What would need to be true (bull case)

  • If the investment pipeline converts into acquisitions at similar yields, growth in per-share earnings could continue on the basis of updated 2026 guidance 3.
  • A balance sheet with net debt below two times EBITDA and access to credit lines could let the company fund growth without major pressure 3.
  • An aging population and positive Medicare rate adjustments could support demand and tenant revenue over the long term 12.

What would break the thesis

  • If financing costs stay high, acquisitions could become less profitable, limiting growth 2.
  • Dependence on a few large operators could expose the company to sudden losses if one faces financial difficulty 1.
  • Medicaid rate cuts and wage pressures could weaken operator margins and their ability to pay rent 12.

What to watch

  • Progress of the pipeline investments and their stabilized yieldsQ3 2026
  • Rent collection and the condition of major tenants, especially EnsignQ3 2026
  • Update to 2026 Normalized FFO and FAD guidanceQ3 2026
  • Application of Medicare SNF rates for fiscal 2027 and state Medicaid rules2027

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

CareTrust REIT generates revenue mainly by leasing healthcare properties to operators under triple-net leases, where the tenant bears property costs including taxes, insurance and maintenance 1. The company also holds mortgage secured loans, mezzanine loans and preferred equity investments, and from December 2025 began building a SHOP platform under the RIDEA structure 13. Its growth strategy targets acquisitions across a diverse set of operators, possibly including international markets 1.

The Care REIT plc acquisition of May 2025 expanded operations in the United Kingdom, where the company now holds a significant part of its portfolio 1. At year-end 2025 and at June 30, 2026, the highest concentrations by rental income were in California, the U.K., Texas and Tennessee 12. The company reported collecting approximately 100% of contractual rents and interest in the second quarter of 2026 23.

On the funding side, the company used equity issuances, at-the-market programs and unsecured credit lines, and at the reporting date had net debt of 1.01 times annualized normalized run-rate EBITDA 13. The quarterly dividend of 0.39 USD per share was maintained, with a payout ratio of about 76% of normalized FAD 3.

Segments

Skilled nursing facilities (SNF)

Skilled nursing facilities form the core of the portfolio, with 366 properties at year-end 2025, of which 236 were owned directly or in consolidated joint ventures 1. Revenue depends on Medicare and Medicaid reimbursement, and changes to state rates can directly affect tenants' ability to pay 1.

Senior housing and other properties

The senior housing segment included 208 communities at year-end 2025, covering assisted living, independent living and memory care, as well as 131 properties classified as U.K. Care Homes 1. The SHOP platform, where the company bears operating costs through third-party managers, carries higher operating risk than triple-net rent 13.

Related real estate investments

Related investments include secured loans, mezzanine loans, preferred equity and a financing receivable, whose carrying value rose visibly through mid-2026 12. This segment offers higher yields but depends on the borrowers' ability to meet their obligations 1.

Market context

The skilled nursing and senior housing market is large and highly fragmented, with numerous local and regional providers, which creates acquisition and consolidation opportunities 1. Demand is supported by an aging population and the shift of care to lower-cost settings, although the number of SNFs has declined modestly in recent years 1. Financing costs and inflation could slow the pace of investment and pressure tenants 13.

The regulatory environment remains a key factor, with Medicare and Medicaid rate adjustments and wage pressures in California 12. If these pressures intensify, operators could have fewer resources to pay rent 1.

Trends

  • Aging populationtailwind

    A growing elderly population could support long-term demand for skilled nursing and senior housing services 1.

  • Medicare rate increasestailwind

    Medicare payment updates for SNFs could partly offset rising operator costs, supporting their ability to pay rent 12.

  • Financing costsheadwind

    Higher interest rates and market volatility increase the cost of capital for acquisitions and may reduce returns on new investments 2.

  • Medicaid and wage regulationmixed

    Medicaid rate cuts in some states and minimum wage increases in California could raise operator costs, though effects differ by state 12.

Competitive position

The company competes with other healthcare REITs that own care properties, as well as private investors buying portfolios in the sector 1. Market fragmentation creates opportunities but also competition for quality assets.

Over the longer term, advantages may come from operator relationships and the ability to structure complex transactions, including in the United Kingdom 13. If other investors become more active, acquisition prices could rise 1.

  • Ensign GroupENSG

    A major operator of properties owned by CareTrust and its principal tenant, which makes the relationship economically dependent on it 1.

  • Other healthcare REITs

    Investors in healthcare real estate that compete for the same acquisitions and operators 1.

  • Private healthcare investors

    Funds and institutional investors buying care facility portfolios, influencing transaction prices 1.

News & filings

In the press

The latest news item in our archive is from 16 Sept 2026; the newest SEC filing is from 30 Oct 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.

SEC filings

  • Current report30 Oct 2026
    Material agreement · Creation of a direct financial obligation · Financial statements and exhibits
  • Current report02 Oct 2026
    Acquisition or disposition of assets · Regulation FD disclosure · Financial statements and exhibits
  • Current report06 Aug 2026
    Results of operations · Regulation FD disclosure · Financial statements and exhibits
  • Quarterly report06 Aug 2026
  • Current report21 May 2026
    Other events · Financial statements and exhibits
  • Current report20 May 2026
    Other events · Financial statements and exhibits
  • Current report07 May 2026
    Results of operations · Regulation FD disclosure · Financial statements and exhibits
  • Quarterly report07 May 2026
  • Current report30 Apr 2026
    Shareholder vote
  • Proxy statement13 Mar 2026

Sources

  1. [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / CareTrust REIT, Inc. · 12 Feb 2026
  2. [2] Form 10-Q, quarter ended 2026-06-30 · SEC / CareTrust REIT, Inc. · 06 Aug 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / CareTrust REIT, Inc. · 06 Aug 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.